https://www.epclusa.com/
EPCLUSA® (sofosbuvir/velpatasvir) A Hep C Treatment Option | Patient Site
Discover EPCLUSA® (sofosbuvir/velpatasvir), a prescription medicine used to treat chronic Hep C. See Important Safety Information including Important Warning.
hep c treatmentsofosbuviroptionpatientsite
https://adisinsight.springer.com/patents/800043237
Sofosbuvir/velpatasvir/voxilaprevir - Gilead Sciences - AdisInsight
gilead sciencessofosbuviradisinsight
https://blogs.nejm.org/hiv-id-observations/index.php/velpatasvirsofosbuvir-makes-hcv-treatment-simpler-especially-for-genotypes-2-and-3/2016/07/03/
Velpatasvir/Sofosbuvir Makes HCV Treatment Simpler, Especially For Genotypes 2 and 3 - HIV and ID...
Jul 3, 2016 - One of the ways ID and hepatology hepatitis C experts like to show off is by discoursing on the nuances of cleverly named clinical trials, and how these impact...
https://medlineplus.gov/druginfo/meds/a616034.html
Sofosbuvir and Velpatasvir: MedlinePlus Drug Information
Sofosbuvir and Velpatasvir: learn about side effects, dosage, special precautions, and more on MedlinePlus
sofosbuvirmedlineplusdruginformation
https://boris-portal.unibe.ch/entities/publication/c104ec8c-8925-413a-b675-3830aba6b494
Sofosbuvir/Velpatasvir for 12 Weeks in Genotype 1-4 HCV-Infected Liver Transplant Recipients